TD Cowen Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $53

Benzinga · 3d ago
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $84 to $53.